Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • US pressing India to...

    US pressing India to avoid capping medical device prices, allow withdrawals

    Written by Ruby Khatun Khatun Published On 2017-10-06T10:33:18+05:30  |  Updated On 18 Aug 2021 1:56 PM IST

    New Delhi: The United States is pressing India not to extend price caps on medical devices and wants the government to allow firms to withdraw products from the market if they do not wish to sell at government-determined rates, a U.S. trade official told Reuters.


    Indian Prime Minister Narendra Modi's government has in recent months slashed prices of medical devices such as knee implants and heart stents by up to 75 percent to make them more affordable.


    But the $5 billion Indian medical-technology industry - which counts U.S. firms such as Abbott Laboratories, Boston Scientific Corp, and Johnson & Johnson as key players - has protested these moves, saying they hurt innovation, profits and future investment.


    A senior United States Trade Representative (USTR) official said they were pressing India to not extend price caps to other devices, allow for higher pricing for technologically advanced equipment and let companies withdraw their products if they wish to.


    India last month issued orders which effectively barred companies from any immediate withdrawals of heart stents or knee implants following price capping to ensure the adequate supply of devices for patients. Abbott, for example, wants to withdraw one of its stents saying it's not commercially viable under government-set prices, but India has rejected its plea.


    "It is a principal concern for the United States," the U.S. official said on condition of anonymity.


    India's trade ministry, which co-chairs such discussions under the U.S.-India Trade Policy Forum did not respond to a request for comment. The federal drug pricing regulator referred questions to the department of pharmaceutical, which did not respond to queries.


    Modi, however, has previously said that providing affordable healthcare to patients takes precedence over the interests of companies.


    The government has equated high margins charged for some medical devices with "illegal profiteering". In some cases, these margins can exceed 400 percent.


    The United States has been increasing pressure on India to revise its stance on price caps for medical devices. A person familiar with the matter said assistant USTR Mark Linscott and his delegation last month conveyed their concerns to Indian trade officials in New Delhi.


    In May, a group of U.S. Congress members urged India to reconsider its decision to cap prices of stents, which are tiny wire mesh tubes used to treat blocked arteries.


    Tanoubi Ngangom, an associate fellow for healthcare at the New Delhi-based Observer Research Foundation, said India must continue to develop policies based on its requirements and not succumb to diplomatic pressure.


    "Indian government should retain a pro-public health stance on pricing medical devices to ensure access to affordable healthcare," she said.


    (Reporting by Aditya Kalra; Editing by Sanjeev Miglani & Shri Navaratnam)

    Abbottallow firmsavoidBoston ScientificcappinggovernmentHealthcareHealthcare Newsheart stentsIndiaknee implantsmarketmedical devicemedical devices newsNarendra ModipressingpricesPrime MinisterproductsUSwithdraw
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok